The 2022 PQA Annual Meeting takes place May 3-5 in Baltimore. This will be our first in-person annual meeting in three years. It is our time to reconnect, learn, network and engage in our shared effort to advance healthcare quality.
PQA has created a new Social Determinants of Health (SDOH) Resource Guide that profiles real-world SDOH services that are promising for improving the quality and safety of medication use with a focus on screenings, referrals and interventions conducted by or involving pharmacists or pharmacies. Richard Schmitz, PQA’s Chief Engagement Officer, provides insights on the guide, it’s origins and what’s next in this Q&A blog.
PQA’s Board of Directors represents a diverse group of thought leaders and experts in healthcare, who understand how medication optimization improves patient outcomes and supports a value-based care system. Their expertise helps PQA advance the safe and appropriate use of medicines. This blog is one in a series profiling PQA's Board members.
PQA has published nearly 80 blogs this year, providing insights and updates on our work to improve medication use quality. As we close out 2021, here’s a look back at the top five blogs of the year.
Amidst an incredibly uncertain time in our world’s history, 2021 will stand out as a year of milestones. This year, we witnessed the successful deployment of several mRNA vaccines and development of therapeutics to assist in the fight against COVID-19. This effort was one of the most extraordinary feats of expedited scientific discovery and innovation ever experienced.
PQA’s talented staff is dedicated to improving medication safety, adherence and appropriate use. As experts in measure development, research, education and convening, they lead the implementation of PQA’s quality initiatives to support better medication use and high-quality care. This blog is one in a series profiling PQA's staff.
The PQA Quality Forum Webinar is a regular, recurring series on healthcare quality topics with a focus on medication use and medication services. It is a forum for educating and engaging with PQA members and quality-focused healthcare professionals.
Prescription opioid-related deaths are one of the leading preventable public health problems. High-risk prescribing practices have contributed to the opioid overdose epidemic. These include overlapping opioid and benzodiazepine prescriptions, prescribing high-dose opioids and using multiple prescribers or pharmacies for opioid prescriptions.
The PQA Quality Forum Webinar is a recurring series on healthcare quality topics which focus on medication use and medication services. The quality forum creates an opportunity for education and engagement with PQA members and quality-focused healthcare professionals.
PQA members are currently voting on three measures up for endorsement and two up for retirement.
PQA’s Board of Directors represents a diverse group of thought leaders and experts in healthcare, who understand how medication optimization improves patient outcomes and supports a value-based care system. Their expertise helps PQA advance the safe and appropriate use of medicines. This blog is one in a series profiling PQA's Board members.
The Pharmacy Quality Alliance (PQA) has developed a 3-hour online continuing education (CE) course on “Measuring Quality to Improve HIV Medication Use.” Launched September 8, the course complements CE and training programs that are focused on clinical practice.
PQA is a non-profit organization with 250 diverse members across healthcare. Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.
PQA’s Board of Directors represents a diverse group of thought leaders and experts in healthcare, who understand how medication optimization improves patient outcomes and supports a value-based care system. Their expertise helps PQA advance the safe and appropriate use of medicines. This blog is one in a series profiling PQA's Board members.
Human immunodeficiency virus (HIV) is a complex disease, and its prevention and treatment have progressed through scientific discoveries, clinical training, continuing education, and widespread public health campaigns. However, gaps in knowledge and practice remain, related to quality improvement and especially to medication use.
The Pharmacy Quality Alliance (PQA) continues to forge ahead with our work to develop a set of standard pharmacy performance measures that would be appropriate for use in value-based plan-pharmacy agreements. Over the past 3 years, we have convened and worked with a broad base of industry leaders to identify and vet pharmacy performance measures that meet the needs of pharmacies, payers, and patients—while balancing feasibility and probability for success.
Concepts Could Be Used in Payer-Pharmacy Value-Based Arrangements
One week ago today, PQA members gathered in person for the first time in two years for the 2021 PQA Leadership Summit. The energy, enthusiasm and engagement across this two-day meeting was incredible. It was my first PQA Leadership Summit, and the event reaffirmed my belief that PQA is unique in its collaborative spirit.
PQA offers a variety of student and post-graduate programs, including experiential rotations, internships and fellowships. Each is focused on providing healthcare quality experience to diverse individuals from diverse disciplines.
